The result is a stunning panoramic view that provides the most detailed image yet of the entire galaxy. Astronomers took on the painstaking task of stitching together Hubble Space Telescope images ...

In the midst of body image angst, people tend to forget about the body's important utility, and it does so much for us, too--our bodies get us from point A to point B, for example. Yet many people ...

Sometimes you may receive a combination of therapies, or something else entirely. Oncology (cancer) drugs include a range of therapies and medications, such as chemotherapy drugs, targeted ...

Drug delivery describes the method and approach to delivering drugs or pharmaceuticals and other xenobiotics to their site of action within an organism, with the goal of achieving a therapeutic ...

These Terms of Use ("Agreement") apply to Bing Image Creator ("Image Creator"). Image Creator (formerly known as Image Creator from Designer) allows you to generate ...

The development of nanocarriers for targeted protein delivery requires methods for high-throughput screening in vitro and in vivo. Here authors develop a DNA-barcoded method to identify ...

Jan. 21, 2025 — A new study found that pregnant women are regularly excluded from clinical drug trials that test for safety, raising concerns for the efficacy of these medications for maternal ...

Management of adverse events is a major concern of clinicians who use antipsychotic drugs. The incidence of motor side effects is dose dependent. Atypical antipsychotic drugs are less likely to ...

Santhera Pharmaceuticals will launch its new drug for Duchenne muscular dystrophy in the UK within the next few weeks, after getting confirmation it will be covered by the NHS in all four nations.

Caption: A visual depiction of the KorB-KorA mechanism. The KorB protein (green) is trapped by its partner protein KorA (pink) on plasmid DNA (cyan). This prevents RNA polymerase (grey) from ...

The Scottish Medicines Consortium (SMC) has rejected Daiichi Sankyo’s new cholesterol-lowering drug Nilemdo for use by NHS Scotland, saying the evidence backing the drug isn’t strong enough.